Autopsy report · NCT03208127
DAA Treatment in Donor HCV-positive to Recipient HCV-negative Liver Transplant
Cause of deathFunding or business
“Protocol transitioned to standard of care, no funding available to continue support of research work or data analysis”
Life of this trial
- Registered 5 months before it started.
- Ran for about 3 years 6 months before it stopped.
- 33 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 4
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- End Stage Liver Disease; Hepatitis C
- Interventions
- Treatment with Direct Acting Antiviral tablet
- Participants
- 33
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
“Protocol review had expired and the study had previously been Suspended. There was no funding to continue the study.” - Muscle, Essential Amino Acids, and eXercise in Heart Failure
“There is no longer any funding to support the study” - Assessing the Role of Cariprazine in Improving Cognition in Euthymic Bipolar Patients
“Research support no longer available.” - Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer
“The study team decided to not move forward with enrolling patients because funding was not identified to support the project.” - CBD for Pain Reduction and Opioid Use After Ankle and Tibia Fracture ORIF
“there was no funding to begin the study”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.